RecruitingNCT01429389

Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy

Collection of Whole Blood Specimens from Pregnant Women At Increased Risk of Fetal Chromosomal Abnormality for Use in Development of a Noninvasive Prenatal Test in the Detection of the Relative Quantity of Chromosomal Material in Circulating Cell-Free DNA Extracted from Maternal Plasma

Sponsor

Sequenom, Inc.

Enrollment

2,000 participants

Start Date

May 1, 2011

Study Type

OBSERVATIONAL

Conditions

Down Syndrome Fetal Aneuploidy

Summary

The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with down syndrome and fetal aneuploidy. The study is currently recruiting participants at 14 locations. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(14)

University of Alabama Birmingham

Birmingham, Alabama, United States

Cedars-Sinai Medical Center

Los Angeles, California, United States

Sharp-Rees Stealy Medical Group

San Diego, California, United States

UCSD

San Diego, California, United States

Women's Health Care Research

San Diego, California, United States

Specialty Obstetrics of San Diego

San Diego, California, United States

Reproductive Genetics Institute

Chicago, Illinois, United States

University of Iowa Health Care

Iowa City, Iowa, United States

Henry Ford Hospital

Detroit, Michigan, United States

Spectrum Health

Grand Rapids, Michigan, United States

The Cooper Health System

Camden, New Jersey, United States

Medical University of South Carolina

Charleston, South Carolina, United States

IWK Health Centre

Halifax, Nova Scotia, Canada

North York General Hospital

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01429389

Related Trials

Natural History of Dysregulation and Aging of the Immune System in People With Trisomy 21 With and Without Thymectomy

NCT074162011 location

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

NCT0427840451 locations

Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)

NCT055089717 locations

Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition

NCT052317981 location

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

NCT04546399225 locations